SK bioscience and Sanofi have announced plans for global Phase III studies, which will assess the safety and immunogenicity ...

A traffic stop on Interstate 65 turned into a high-speed pursuit, ending with the arrest of three people. Around 10:30 p.m. on January 31, Indiana State Police Trooper Bradley Howell stopped a 2015 ...

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

SYRACUSE, NEW YORK / ACCESS Newswire / January 21, 2025 / Repair Biotechnologies, Inc. ( a biotechnology company developing first-in-class therapies capable of rapidly reducing atherosclerotic plaque, ...

Repair Biotechnologies, Inc. ( a biotechnology company developing first-in-class therapies capable of rapidly reducing atherosclerotic plaque, is pleased to announce that it has ...

The company claims its Fertilo system can mature eggs outside the body using 80% fewer hormonal injections than typical ...

In the Opportunity Research report, analyst Rob Goldman reviews clinical and preclinical data on OKYO's lead candidate, the Company's inherent first-mover opportunities in the industry, upcoming ...

The Phase I trial will evaluate the safety and efficacy of the company’s drug which targets tumours whilst leaving normal ...

IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC designed to precisely target Nectin-4, a cell adhesion molecule that is overexpressed in several types of solid tumors, including ...

ZL-6201 has demonstrated encouraging preclinical data with an IND expected to be filed in 2025 ... on developing cancer therapies with ADC drugs and enriches our global oncology pipeline ...

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ...